All articles tagged with #rtms
New research demonstrates that low-intensity repetitive transcranial magnetic stimulation (rTMS) can partially reverse synaptic damage in mouse models of Alzheimer's disease by increasing the turnover of specific synaptic structures, suggesting potential therapeutic benefits for AD patients.
A randomized clinical trial has found that repetitive transcranial magnetic stimulation (rTMS) can improve event-based prospective memory in individuals with schizophrenia. The study compared 50 schizophrenia patients with healthy controls and found that while both event-based and time-based prospective memory scores were initially lower in patients, rTMS significantly improved event-based memory to levels comparable with controls. However, time-based memory did not show similar improvement. These findings offer a potential therapeutic avenue for addressing memory impairments in schizophrenia.
Chronic caffeine consumption may diminish brain plasticity, specifically long-term potentiation (LTP), which is crucial for learning and memory. This could potentially impact the effectiveness of treatments like repetitive transcranial magnetic stimulation (rTMS), which relies on LTP induction. However, further research is needed to fully understand the effects of habitual caffeine use on brain plasticity and learning mechanisms.
Noninvasive brain stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS) show promise in reducing spasticity in multiple sclerosis (MS) patients, according to a review study. However, evidence for transcranial direct current stimulation (tDCS) was limited. More clinical trials with long-term follow-up are needed to determine the optimal approach for treating spasticity in MS. Spasticity, characterized by muscle tightness and spasms, is a challenging symptom to manage in MS patients and can impact mobility and overall quality of life.